Works by Wasserman, Richard L.

Results: 29

Clinical Practice Experience with HyQvia in Adults Using Alternative Dosing Regimens and Pediatric Patients: A Retrospective Study.

Published in:

2020

By:

Wasserman, Richard L.;
HyQvia Experience Study Group

Publication type:

journal article

Recurrent Granulibacter bethesdensis Infections and Chronic Granulomatous Disease.

Published in:

Emerging Infectious Diseases, 2010, v. 16, n. 9, p. 1341, doi. 10.3201/eid1609.091800

By:

Greenberg, David E.;
Shoffner, Adam R.;
Zelazny, Adrian M.;
Fenster, Michael E.;
Zarember, Kol A.;
Stock, Frida;
Ding, Li;
Marshall-Batty, Kimberly R.;
Wasserman, Richard L.;
Welch, David F.;
Kanakabandi, Kishore;
Sturdevant, Dan E.;
Virtaneva, Kimmo;
Porcella, Stephen F.;
Murray, Patrick R.;
Malech, Harry L.;
Holland, Steven M.

Publication type:

Article

Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency Diseases.

Published in:

Journal of Clinical Immunology, 2025, v. 45, n. 1, p. 1, doi. 10.1007/s10875-025-01862-6

By:

Patel, Niraj C.;
Walter, Jolan E.;
Wasserman, Richard L.;
Rubinstein, Arye;
Kankirawatana, Suthida;
Shepherd, Meagan W.;
Greco, Erin;
Li, Zhaoyang;
Russo-Schwarzbaum, Sharon;
Saeed-Khawaja, Shumyla;
McCoy, Barbara;
Yel, Leman

Publication type:

Article

Long-Term Safety of Facilitated Subcutaneous Immunoglobulin 10% Treatment in US Clinical Practice in Patients with Primary Immunodeficiency Diseases: Results from a Post-Authorization Safety Study.

Published in:

Journal of Clinical Immunology, 2024, v. 44, n. 8, p. 1, doi. 10.1007/s10875-024-01769-8

By:

Rubinstein, Arye;
Mabudian, Mohsen;
McNeil, Donald;
Patel, Niraj C.;
Wasserman, Richard L.;
Gupta, Sudhir;
Carrasco, Paz;
Chen, Jie;
Garcia, Enrique;
Nagy, Andras;
Yel, Leman

Publication type:

Article

Microbiological, Physicochemical, and Immunological Analysis of a Commercial Cashew Nut-Based Yogurt.

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 8267, doi. 10.3390/ijms21218267

By:

Mattison, Christopher P.;
Aryana, Kayanush J.;
Clermont, Kristen;
Prestenburg, Eric;
Lloyd, Steven W.;
Grimm, Casey C.;
Wasserman, Richard L.

Publication type:

Article

Validation of inducible basophil biomarkers: Time, temperature and transportation.

Published in:

Cytometry. Part B, 2021, v. 100, n. 6, p. 632, doi. 10.1002/cyto.b.21991

By:

Kim, Theodore;
Yu, Jing;
Li, Henry;
Scarupa, Mark;
Wasserman, Richard L.;
Economides, Athena;
White, Martha;
Ward, Carla;
Shah, Atul;
Jones, Douglas;
Rathkopf, Melinda;
Frye, Kelly;
Aybar, Ahmet;
Shayegan, Shahrooz;
Enav, Benjamin;
Ispas, Laura;
Loizou, Denise;
Fitzhugh, David;
Tracy, James;
Friedlander, James

Publication type:

Article

Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary Immunodeficiency.

Published in:

Clinical Pharmacokinetics, 2011, v. 50, n. 6, p. 405, doi. 10.2165/11587030-000000000-00000

By:

Wasserman, Richard L.;
Melamed, Isaac;
Nelson Jr., Robert P.;
Knutsen, Alan P.;
Fasano, Mary Beth;
Stein, Mark R.;
Rojavin, Mikhail A.;
Church, Joseph A.

Publication type:

Article

In vitro digestion of soluble cashew proteins and characterization of surviving Ig E-reactive peptides.

Published in:

Molecular Nutrition & Food Research, 2014, v. 58, n. 4, p. 884, doi. 10.1002/mnfr.201300299

By:

Mattison, Christopher P.;
Grimm, Casey C.;
Wasserman, Richard L.

Publication type:

Article

Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials.

Published in:

Journal of Clinical Immunology, 2018, v. 38, n. 8, p. 864, doi. 10.1007/s10875-018-0560-5

By:

Jolles, Stephen;
Rojavin, Mikhail A.;
Lawo, John-Philip;
Nelson, Robert;
Wasserman, Richard L.;
Borte, Michael;
Tortorici, Michael A.;
Imai, Kohsuke;
Kanegane, Hirokazu

Publication type:

Article

Correction to: Use of Genetic Testing for Primary Immunodeficiency Patients.

Published in:

2018

By:

Heimall, Jennifer R.;
Hagin, David;
Hajjar, Joud;
Henrickson, Sarah E.;
Hernandez-Trujillo, Hillary S.;
Itan, Yuval;
Kobrynski, Lisa;
Paris, Kenneth;
Torgerson, Troy R.;
Verbsky, James W.;
Wasserman, Richard L.;
Hsieh, Elena W. Y.;
Bleesing, Jack J.;
Chou, Janet S.;
Lawrence, Monica G.;
Marsh, Rebecca A.;
Rosenzweig, Sergio D.;
Orange, Jordan S.;
Abraham, Roshini S.

Publication type:

Correction Notice

Correction to: Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials.

Published in:

2018

By:

Ballow, Mark;
Wasserman, Richard L.;
Jolles, Stephen;
Chapel, Helen;
Berger, Mel;
Misbah, Siraj A.

Publication type:

Correction Notice

Use of Genetic Testing for Primary Immunodeficiency Patients.

Published in:

Journal of Clinical Immunology, 2018, v. 38, n. 3, p. 320, doi. 10.1007/s10875-018-0489-8

By:

Heimall, Jennifer R.;
Hagin, David;
Hajjar, Joud;
Henrickson, Sarah E.;
Hernandez-Trujillo, Hillary S.;
Tan, Yuval;
Kobrynski, Lisa;
Paris, Kenneth;
Torgerson, Troy R.;
Verbsky, James W.;
Wasserman, Richard L.;
Hsieh, Elena W. Y.;
Blessing, Jack J.;
Chou, Janet S.;
Lawrence, Monica G.;
Marsh, Rebecca A.;
Rosenzweig, Sergio D.;
Orange, Jordan S.;
Abraham, Roshini S.

Publication type:

Article

Prospective Study of Rapid Relief Provided by C1 Esterase Inhibitor in Emergency Treatment of Acute Laryngeal Attacks in Hereditary Angioedema.

Published in:

Journal of Clinical Immunology, 2010, v. 30, n. 6, p. 823, doi. 10.1007/s10875-010-9442-1

By:

Craig, Timothy J.;
Wasserman, Richard L.;
Levy, Robyn J.;
Bewtra, Againdra K.;
Schneider, Lynda;
Packer, Flint;
Yang, William H.;
Keinecke, Heinz-Otto;
Kiessling, Peter C.

Publication type:

Article

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency.

Published in:

Journal of Clinical Immunology, 2010, v. 30, n. 5, p. 734, doi. 10.1007/s10875-010-9423-4

By:

Hagan, John B.;
Fasano, Mary B.;
Spector, Sheldon;
Wasserman, Richard L.;
Melamed, Isaac;
Rojavin, Mikhail A.;
Zenker, Othmar;
Orange, Jordan S.

Publication type:

Article

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies.

Published in:

Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.707463

By:

Perez, Elena E.;
Hébert, Jacques;
Ellis, Anne K.;
Alpan, Oral;
Lumry, William R.;
Shapiro, Ralph;
Suez, Daniel;
Mandujano, J. Fernando;
Wasserman, Richard L.

Publication type:

Article

Ataxia-telangiectasia Associated with Sarcoidosis.

Published in:

Pediatric Dermatology, 1986, v. 3, n. 4, p. 339, doi. 10.1111/j.1525-1470.1986.tb00537.x

By:

Fleck, Robin M.;
Myers, Linda K.;
Wasserman, Richard L.;
Tigelaar, Robert E.;
Freeman, Robert G.

Publication type:

Article

Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment.

Published in:

Allergy & Asthma Proceedings, 2021, v. 42, n. 6, p. 489, doi. 10.2500/aap.2021.42.210082

By:

Wasserman, Richard L.

Publication type:

Article

C1-inhibitor therapy for hereditary angioedema attacks: Prospective patient assessments of health-related quality of life.

Published in:

Allergy & Asthma Proceedings, 2012, v. 33, n. 5, p. 427, doi. 10.2500/aap.2012.33.3597

By:

Bewtra, Againdra K.;
Levy, Robyn J.;
Jacobson, Kraig W.;
Wasserman, Richard L.;
Machnig, Thomas;
Craig, Timothy J.

Publication type:

Article

Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.

Published in:

Allergy & Asthma Proceedings, 2012, v. 33, n. 4, p. 354, doi. 10.2500/aap.2012.33.3589

By:

Craig, Timothy J.;
Bewtra, Againdra K.;
Hurewitz, David;
Levy, Robyn;
Janss, Gerti;
Jacobson, Kraig W.;
Packer, Flint;
Bernstein, Jonathan A.;
Rojavin, Mikhail A.;
Machnig, Thomas;
Keinecke, Heinz-Otto;
Wasserman, Richard L.

Publication type:

Article

Hereditary angioedema: Validation of the end point time to onset of relief by correlation with symptom intensity.

Published in:

Allergy & Asthma Proceedings, 2011, v. 32, n. 1, p. 36, doi. 10.2500/aap.2011.32.3404

By:

Bernstein, Jonathan A.;
Ritchie, Bruce;
Levy, Robyn J.;
Wasserman, Richard L.;
Bewtra, Againdra K.;
Hurewitz, David S.;
Obtulowicz, Krystyna;
Reshef, Avner;
Moldovan, Dumitru;
Shirov, Todor;
Grivcheva-Ganovska, Vesna;
Kiessling, Peter C.;
Keinecke, Heinz-Otto;
Craig, Timothy J.

Publication type:

Article

Real-world assessment of a metered-dose inhaler with integrated dose counter.

Published in:

Allergy & Asthma Proceedings, 2006, v. 27, n. 6, p. 486, doi. 10.2500/aap.2006.27.2921

By:

Wasserman, Richard L.;
Sheth, Ketan;
Lincourt, William R.;
Locantore, Nicholas W.;
Rosenzweig, Jacqueline Carranza;
Crim, Courtney

Publication type:

Article

Information needs of patients considering oral immunotherapy for food allergy.

Published in:

Clinical & Experimental Allergy, 2022, v. 52, n. 12, p. 1391, doi. 10.1111/cea.14225

By:

Mack, Douglas Paul;
Greenhawt, Matthew;
Turner, Paul J.;
Wasserman, Richard L.;
Hanna, Mariam A.;
Shaker, Marcus;
Hughes, Sarah W.;
del Río, Pablo Rodríguez

Publication type:

Article

RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.

Published in:

Expert Review of Clinical Immunology, 2017, v. 13, n. 12, p. 1107, doi. 10.1080/1744666X.2017.1389647

By:

Wasserman, Richard L.;
Greener, Benjamin N.;
Mond, James

Publication type:

Article

Hizentra for the treatment of primary immunodeficiency.

Published in:

Expert Review of Clinical Immunology, 2014, v. 10, n. 10, p. 1293, doi. 10.1586/1744666X.2014.957678

By:

Wasserman, Richard L

Publication type:

Article

A new intravenous immunoglobulin (BIVIGAM<sup>®</sup>) for primary humoral immunodeficiency.

Published in:

Expert Review of Clinical Immunology, 2014, v. 10, n. 3, p. 325, doi. 10.1586/1744666X.2014.891438

By:

Wasserman, Richard L

Publication type:

Article

Safety of l-proline as a stabilizer for immunoglobulin products.

Published in:

Expert Review of Clinical Immunology, 2012, v. 8, n. 2, p. 169, doi. 10.1586/ECI.11.97

By:

Hagan, John B.;
Wasserman, Richard L.;
Baggish, Jeffrey S.;
Spycher, Martin O.;
Berger, Melvin;
Shashi, Vandana;
Lohrmann, Emanuel;
Sullivan, Kathleen E.

Publication type:

Article

Long-term adverse events, efficacy, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin in patients aged < 18 years with primary immunodeficiency diseases.

Published in:

Revista Alergia de Mexico, 2018, v. 65, p. 124

By:

Laguado, Lina;
Wasserman, Richard L.;
Melamed, Isaac;
Kobrynski, Lisa;
Gupta, Sudhir;
Engl, Werner;
Leibl, Heinz;
Yel, Leman

Publication type:

Article

Local adverse reaction rates decreased over time during treatment with recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin G (fSCIG) in patients with primary immunodeficiency diseases in the fSCIG phase 3 studies.

Published in:

Revista Alergia de Mexico, 2018, v. 65, p. 122

By:

Laguado, Lina;
Stein, Mark;
Wasserman, Richard L.;
Melamed, Isaac;
Gupta, Sudhir;
Kobrynski, Lisa;
Rubinstein, Arye;
Rabbat, Christopher J.;
Engl, Werner;
McCoy, Barbara;
Leibl, Heinz;
Yel, Leman

Publication type:

Article

Persistent Enterovirus Infection in Culture-Negative Meningoencephalitis: Demonstration by Enzymatic RNA Amplification.

Published in:

Journal of Infectious Diseases, 1990, v. 161, n. 4, p. 787, doi. 10.1093/infdis/161.4.787

By:

Rotbart, Harley A.;
Kinsella, John R;
Wasserman, Richard L.

Publication type:

Article